drugset / Trial / NCT04135820
A Phase I Study to Determine the Effect of Food on the Pharmacokinetic Profile of BPI-7711
RandomizedCrossoverOpen-labelOther
Summary
This is an open-label, randomised, single-dose, cross-over phase I study to evaluate the effect of food on the pharmacokinetic profile of BPI-7711 in Chinese healthy male subjects.
Timeline
- Start
- 2019-12-17
- Primary completion
- 2020-03-25
- Completion
- 2020-03-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rezivertinib | Small molecule | 180 mg | — |